Key result
Topical application of phosphatidylcholine nanovesicular gel significantly reduced dorsal fat percentage and total lipid content in diet-induced obese rats compared to the untreated model group, without causing skin irritation.
Why the study?
A novel non-invasive topical treatment was evaluated to combine ease of application with the absence of side effects associated with multi-injection mesotherapy systems for localized obesity.
Does topical soybean phosphatidylcholine-based nanovesicular gel reduce body weight and fat content in male albino rats compared to mesotherapy injections?
Does topical soybean phosphatidylcholine-based nanovesicular gel reduce body weight and fat content in male albino rats compared to mesotherapy injections?
Topical soybean phosphatidylcholine-based nanovesicular gel is an effective, non-invasive alternative to mesotherapy injections for reducing localized fat in a rat model.
Answers are grounded in this paper and cite their sources.
May enable non-invasive topical obesity treatment avoiding injections; hypothesis-generating in animals, human trials needed.
A novel non-invasive approach for treatment of localized obesity is introduced utilizing carbopol gel containing soybean phosphatidylcholine based nanovesicular system for topical application. The tested systems are designed to combine the absence of side effects of the multi-injection system used in mesotherapy and the ease of application. Nanovesicles such as transfersomes and transethosomes were prepared using soybean phosphatidylcholine, tween 80, sodium deoxycholate, cremophor, and oleic acid in different concentrations determined according to 3D-optimal mixture experimental design. The prepared vesicles were evaluated and incorporated into carbopol gel. The stability of the prepared nanovesicles and gel was examined after storage for six months at 4C. In-vivo and In-vitro studies were performed using male albino rats. Performed experiments on rats showed that the three formulations of choice (F4e, F11e and Et11) succeeded to reduce body weight, percentage dorsal fat and total lipid content significantly (P<0.05) without appearance of any sign of skin irritation compared to PC marketed injections (Adipoforte) used in mesotherapy. PC nanovesicular gel, containing transethosomes (F4e, F11e and Et11), can be significantly considered as effective noninvasive treatment for localized obesity as an alternative to multiinjections for mesotherapy.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied Localized obesity (n=48). Phosphatidylcholine nanovesicular gel vs. Untreated model group (high-fat diet) and PC marketed injection was evaluated on Dorsal fat percentage (%PDF) (p=<0.0001). Topical application of phosphatidylcholine nanovesicular gel significantly reduced dorsal fat percentage and total lipid content in diet-induced obese rats compared to the untreated model group, without causing skin irritation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: